The report "Oligonucleotide
Synthesis Market by Product & Services (Primer, Probe, Custom,
Predesigned, Reagent Equipment), Application (Research, PCR, Gene, DNA, NGS,
Diagnostic, RNAI), End user (Academic, Pharmaceutical, Biotechnology) -
Forecasts to 2021" ,The global oligonucleotide synthesis
market is expected to reach USD 2.20 Billion by 2021 from USD 1.33 Billion in
2016, at a CAGR of 10.6% during the forecast period.
Browse 229 market data tables and
53 figures spread through 248 pages and in-depth TOC on “Oligonucleotide Synthesis Market “
http://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html
Early buyers will receive 10% customization on this reports
Early buyers will receive 10% customization on this reports
The growth of this market is mainly driven
by factors such as increasing R&D expenditure in pharmaceutical and
biotechnology companies, increased use in clinical applications and molecular
diagnostics, increasing government investments for the development of genomics,
and evolving significance of RNA-interference oligos in therapeutics and
diagnostics are key factors driving market growth for oligonucleotide synthesis.
The
report segments the oligonucleotide synthesis market based on product and
services, applications, end user, and region. On the basis of products and
services, the oligonucleotide synthesis market is segmented into synthesized
oligonucleotides, reagents, and equipment. Synthesized oligonucleotides are
expected to account for the largest share of oligonucleotide synthesis market,
in 2016. The growth of the synthesized oligonucleotides segment is attributed
to the increasing number of applications of synthesized oligonucleotides in
research, diagnostics, and therapeutics. The rising demand for custom oligos
also contributes to the growth of the synthesized oligonucleotides market.
On the
basis of application the oligonucleotide synthesis market is further segmented
into research, diagnostic and therapeutics. Research segment is expected to
account for the largest share of oligonucleotide synthesis market in 2016.
Diagnostic segment is expected to grow at the highest CAGR during the forecast
period. The growth of this segment is mainly attributed to the emerging
application of molecular diagnostics (MDx) and genetic testing. The increasing
use of technologies such as DNA microarrays in the analysis of biological
samples and developing molecular oncology diagnostics tests also contribute in
the growth of molecular diagnostics market.
On the
basis of end-user the oligonucleotide synthesis market is categorized into
academic research institutes, diagnostic laboratories, pharmaceutical and
biotechnology companies, and other end users (private research institutes and
hospitals). In 2016, the academic research institutes segment is expected to be
the major end-user segment in the oligonucleotide synthesis market. Academic
researchers primarily use oligonucleotides for various applications in genetic
engineering, polymerase chain reaction (PCR) activities, and high-throughput
sequencing.
The Sample Report For This Report@
The
oligonucleotide synthesis market is segmented into North America, Europe,
Asia-Pacific, Latin America and Middle East & Africa. North America is
expected to account for the largest share of this market in 2016. However, the
Asia-Pacific market is expected to grow at the highest CAGR, mainly due to the
growing availability of synthesized oligos, along with an increase in R&D funding
and activities in the APAC region. Furthermore, the increasing focus of
prominent players on APAC is another factor driving the growth of this market.
The
oligonucleotide synthesis market is a highly fragmented market, with several
big and emerging players. Key market players include Bioautomation Corporation
(U.S.), L.G.C Biosearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany),
Eurogentec S.A (Belgium), GE Healthcare (U.S.), Integrated DNA Technologies
(IDT) (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc.
(U.S.), Agilent Technologies (U.S.), Nitto Denko Avecia Inc. (U.S.).
Get The
PDF Brochure For This Report@
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B
research on 30,000 high growth niche opportunities/threats which will impact
70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers
worldwide including 80% of global Fortune 1000 companies as clients. Almost
75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at
MarketsandMarkets™ are tracking global high growth markets following the
"Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and its
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this year
for their revenue planning and help them take their innovations/disruptions
early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive
intelligence and market research platform, "RT" connects over 200,000
markets and entire value chains for deeper understanding of the unmet insights
along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
No comments:
Post a Comment